Conversion of CLNs

AI SummaryClose X

Roquefort Therapeutics plc has announced the conversion of £80,000 in convertible loan notes, resulting in the issuance of 6,282,264 new ordinary shares. The conversion, which includes accrued interest at 12.5% per annum, occurred at prices of 1.81p for £30,000 and 1.29p for £50,000 of the notes. Following this conversion, the company has £257,894 in convertible loan notes outstanding. The new shares are expected to be admitted to trading on the London Stock Exchange around December 16, 2025, bringing the total issued share capital to 163,726,294 ordinary shares.

Disclaimer*

UK 100

Latest directors dealings